MoneyWorks4Me

The sales declined to Rs. 5039.20 millions for the March 2024 quarter as compared to Rs. 5872.10 millions during the corresponding quarter last year.The Net Profit of the company slipped to Rs. 281.90 millions from Rs. 652.70 millions, a decline of -56.81% on QoQ basis.Operating profit for the quarter ended March 2024 decreased to 576.00 millions as compared to 1045.10 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 5039.20 5872.10 -14.18 21327.90 22171.10 -3.80 21327.90 22171.10 -3.80
Other Income 75.20 87.20 -13.76 300.70 255.70 17.60 300.70 255.70 17.60
PBIDT 576.00 1045.10 -44.89 2615.90 2520.90 3.77 2615.90 2520.90 3.77
Interest 34.10 48.80 -30.12 161.00 164.70 -2.25 161.00 164.70 -2.25
PBDT 541.90 996.30 -45.61 2454.90 2356.20 4.19 2454.90 2356.20 4.19
Depreciation 164.20 121.00 35.70 628.50 461.30 36.25 628.50 461.30 36.25
PBT 377.70 875.30 -56.85 1826.40 1894.90 -3.61 1826.40 1894.90 -3.61
TAX 95.80 222.60 -56.96 472.20 495.10 -4.63 472.20 495.10 -4.63
Deferred Tax 45.60 36.80 23.91 102.10 32.50 214.15 102.10 32.50 214.15
PAT 281.90 652.70 -56.81 1354.20 1399.80 -3.26 1354.20 1399.80 -3.26
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 11.43 17.80 -35.78 12.27 11.37 7.87 12.27 11.37 7.87
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..